Mood and Anxiety Research

Mood and Anxiety Research, Inc. is a clinical research organization and medical practice specializing in the study and treatment of mood and anxiety disorders, with a particular focus on Borderline Personality Disorder (BPD). Founded and led by Dr. Paul J. Markovitz, the company has served as a sponsor and investigator site for various clinical trials, including Phase 3 studies of transdermal selegiline for BPD. The organization also engages in biomarker discovery for affective disorders and provides consulting services to the pharmaceutical industry. Based in Fresno, California, it bridges the gap between clinical practice and neuropsychiatric drug development.